Clinical Trials Directory

Trials / Completed

CompletedNCT04901065

Xylocaine to Freeze During Unpleasant Nasopharyngeal Swabs

Xylocaine to Freeze During Unpleasant Nasopharyngeal Swabs: a Randomized, Double-Blinded, Placebo Controlled-Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
88 (actual)
Sponsor
Evelyne D.Trottier · Academic / Other
Sex
All
Age
8 Years – 17 Years
Healthy volunteers
Not accepted

Summary

Since the beginning of the COVID-19 pandemic, nasopharyngeal swabs (NPS) have been recommended to detect the virus. This procedure has been reported to be painful by 85% of children The aim of the study was to assess whether pretreatment with topical lidocaine reduces the discomfort experienced by children during a nasopharyngeal swab. This was a RCT among children aged 8-17 years old who need a NPS. The primary outcome was pain intensity as measured by the Visual Analog Scale .

Conditions

Interventions

TypeNameDescription
DRUGXylocaineThe study intervention was the administration of 10 mg of intranasal lidocaine in one nostril using 1 spray of 0.1mL of a 10% lidocaine solution 5 minutes before NPS. This was done using the standard long nozzle
DRUGPlaceboThe control group received the placebo with the same application technique using an empty bottle of lidocaine 10% with the same long nozzle for delivery

Timeline

Start date
2021-05-11
Primary completion
2021-06-07
Completion
2021-06-07
First posted
2021-05-25
Last updated
2021-09-27

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04901065. Inclusion in this directory is not an endorsement.